Stari
← September 4, 2026 · Full edition
1–3 yearsBiopreservation and laboratory logistics

Room-temperature sample preservation is testing wider laboratory workflows

Spain, Italy and France

Share ↗

The signal

Supplier-reported laboratory installations and repeat kit purchases, a small plasma comparison study and an established French DNA-encapsulation alternative suggest selective room-temperature preservation may expand beyond purified DNA archives. The early opportunity is assay-specific validation and workflow integration, not elimination of all cold storage.

The clue

The early commercial signal is equipment installation and repeat consumable purchases—not a claim that laboratories can abandon refrigeration.

Why it matters

For research organizations and laboratory operators, selective room-temperature storage could change shipping, freezer capacity and sample-handling costs.

Evidence and interpretation

- Observed facts: In July 29 updates, 300K reported installation at the University of Bologna and further kit purchases by FISABIO. A supplier-hosted research poster compared plasma from 15 patients: 16 of 22 measured cytokines showed no significant difference between preservation methods; others differed or varied. Long-term stability remained unestablished. - Interpretation: Procurement and comparative testing are different evidence types, but independent confirmation of broad adoption remains limited. - Speculation: Assay-specific preservation kits and validation services could become a larger supplier opportunity.

Global comparison and alternatives: France’s Imagene already offers dry DNA encapsulation, with documentation referencing studies from the early 2010s. Ambient DNA storage is not new. The tentative expansion is toward additional sample types and workflows—not proof that DNA-preservation results transfer to plasma or other biological material.

What to watch next

Independent longitudinal studies across sample types, repeat consumable orders, retained assay performance and measured end-to-end costs would strengthen the thesis. Biomarker-specific degradation, poor rehydration or preparation costs exceeding refrigeration savings would weaken it.

Original sources

Explore the full edition and the daily choice →

Want to use this trend in your business?

Tell Aik what your team is trying to improve.

Discuss your workflow
Discuss your workflow